National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 51966 [2018-22311]

Download as PDF 51966 Federal Register / Vol. 83, No. 199 / Monday, October 15, 2018 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Post-Baccalaureate Supplemental Application. Graduate Student Application ........... Postdoctoral Fellowship Application Reference Letter ............................... Post-Baccalaureate (Including PostMaster’s) Individuals. Graduate Students ........................... Postdoctoral Candidates .................. PIs, professors, supervisors ............. 50 1 30/60 25 30 50 240 1 1 1 2 2 30/60 60 100 120 Totals ......................................... ........................................................... 370 370 ........................ 305 Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: October 5, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–22319 Filed 10–12–18; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2018–22311 Filed 10–12–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. khammond on DSK30JT082PROD with NOTICES Average time per response (in hours) Type of respondent Dated: October 2, 2018. Patricia M. Busche, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. Number of respondents Number of responses per respondent Form name Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed). Date: November 8–9, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G62A, National Institute of Health, NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20899823, (240) 669–5081, ecohen@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, VerDate Sep<11>2014 21:34 Oct 12, 2018 Jkt 247001 National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: November 5, 2018. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Lee G. Klinkenberg, Ph.D., Scientific Review Program, DEA/NIAID/NIH/ DHHS, 5601 Fishers Lane, MSC–9823, Bethesda, MD 20892–9834, 301–761–7749, lee.klinkenberg@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Sexually Transmitted Infections CRC: Vaccine Development (U19). Date: November 8–9, 2018. PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Total annual burden hour Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Annie Walker-Abbey, Ph.D., Scientific Review Officer, Scientific Review Program, AID/NIH/DHHS, 5601 Fishers Lane, Room 3E70A, Rockville, MD 20852, 240–627–3390, aabbey@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: October 5, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–22312 Filed 10–12–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIH Pathway to Independence Award (K99/R00). Date: October 17, 2018. Time: 8:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\15OCN1.SGM 15OCN1

Agencies

[Federal Register Volume 83, Number 199 (Monday, October 15, 2018)]
[Notices]
[Page 51966]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-22311]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Genomic Centers for Infectious 
Diseases (U19 Clinical Trial Not Allowed).
    Date: November 8-9, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, Room 
3G62A, National Institute of Health, NIAID, 5601 Fishers Lane, MSC 
9823, Bethesda, MD 20899823, (240) 669-5081, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


    Dated: October 5, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-22311 Filed 10-12-18; 8:45 am]
 BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.